HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

José Marco-Contelles Selected Research

Cholinesterases (Cholinesterase)

1/2021(±)-BIGI-3h: Pentatarget-Directed Ligand combining Cholinesterase, Monoamine Oxidase, and Glycogen Synthase Kinase 3β Inhibition with Calcium Channel Antagonism and Antiaggregating Properties for Alzheimer's Disease.
5/2020Acetylcholinesterase Inhibition of Diversely Functionalized Quinolinones for Alzheimer's Disease Therapy.
1/2020Propargylamine-derived multi-target directed ligands for Alzheimer's disease therapy.
12/2019New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition.
8/2018Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.
7/2018Tacripyrimidines, the first tacrine-dihydropyrimidine hybrids, as multi-target-directed ligands for Alzheimer's disease.
10/2017Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H3 R Antagonism for Neurodegenerative Diseases.
11/2016The Antioxidant Additive Approach for Alzheimer's Disease Therapy: New Ferulic (Lipoic) Acid Plus Melatonin Modified Tacrines as Cholinesterases Inhibitors, Direct Antioxidants, and Nuclear Factor (Erythroid-Derived 2)-Like 2 Activators.
6/2016Synthesis and Biological Assessment of Racemic Benzochromenopyrimidinimines as Antioxidant, Cholinesterase, and Aβ1-42 Aggregation Inhibitors for Alzheimer's Disease Therapy.
6/2014Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


José Marco-Contelles Research Topics

Disease

70Alzheimer Disease (Alzheimer's Disease)
11/2021 - 12/2006
11Neuroblastoma
03/2022 - 12/2006
9Stroke (Strokes)
08/2021 - 01/2012
8Ischemia
07/2022 - 09/2012
8Brain Ischemia (Cerebral Ischemia)
06/2022 - 01/2011
8Neurodegenerative Diseases (Neurodegenerative Disease)
03/2022 - 07/2014
5Ischemic Stroke
06/2022 - 10/2017
4Infarction (Infarctions)
07/2022 - 01/2020
4Cognitive Dysfunction
01/2020 - 07/2014
4Amyloid Plaque
01/2020 - 01/2016
3Inflammation (Inflammations)
12/2018 - 05/2013
3Neuroinflammatory Diseases
12/2018 - 01/2016
2Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2022 - 10/2017
2Gliosis
01/2020 - 07/2014
2Parkinson Disease (Parkinson's Disease)
02/2015 - 07/2014
2Dementia (Dementias)
07/2014 - 12/2007
2Cerebrovascular Disorders (Cerebrovascular Occlusion)
06/2013 - 01/2011
2Vascular Diseases (Vascular Disease)
01/2011 - 08/2010
1Gout
01/2022
1Hearing Loss (Hearing Impairment)
01/2021
1Hypoxia (Hypoxemia)
03/2020
1Necrosis
05/2019
1Reperfusion Injury
10/2017
1Brain Injuries (Brain Injury)
01/2017

Drug/Important Bio-Agent (IBA)

25AntioxidantsIBA
07/2022 - 01/2011
20Biological ProductsIBA
08/2021 - 09/2011
17Tacrine (Cognex)FDA Link
01/2021 - 12/2006
14LigandsIBA
01/2021 - 05/2009
14Cholinesterases (Cholinesterase)IBA
01/2021 - 12/2011
13nitronesIBA
06/2022 - 01/2011
13Monoamine Oxidase (MAO)IBA
01/2021 - 09/2011
10Neuroprotective AgentsIBA
07/2022 - 12/2006
10N- ((5- (3- (1- benzylpiperidin- 4- yl)propoxy)- 1- methyl- 1H- indol- 2- yl)methyl)- N- methylprop- 2- yn- 1- amineIBA
01/2020 - 10/2013
9Pharmaceutical PreparationsIBA
06/2022 - 09/2011
9RotenoneIBA
08/2021 - 07/2010
9oligomycin AIBA
08/2021 - 07/2010
8Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2021 - 09/2011
8Donepezil (Aricept)FDA LinkGeneric
08/2018 - 12/2011
7Oxygen (Dioxygen)IBA
06/2022 - 09/2012
7Glucose (Dextrose)FDA LinkGeneric
06/2022 - 09/2012
6Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA
11/2020 - 12/2011
6Cholinergic Agents (Cholinergics)IBA
01/2019 - 12/2007
6MelatoninIBA
01/2017 - 01/2016
5Calcium Channels (Calcium Channel)IBA
01/2021 - 06/2011
5propargylamineIBA
01/2020 - 06/2014
5Oxidoreductases (Dehydrogenase)IBA
01/2020 - 06/2012
5AminesIBA
01/2017 - 12/2011
4Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022 - 05/2013
4Amyloid (Amyloid Fibrils)IBA
08/2021 - 01/2016
4AcetylcholinesteraseIBA
05/2020 - 12/2006
4Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2015
3Superoxides (Superoxide)IBA
03/2022 - 01/2020
3Okadaic AcidIBA
08/2021 - 10/2016
3Free RadicalsIBA
11/2020 - 12/2006
3OxidesIBA
11/2020 - 09/2012
31,4-dihydropyridine (dihydropyridine)IBA
10/2020 - 12/2006
3Scopolamine (Hyoscine)FDA Link
01/2020 - 01/2016
3EnzymesIBA
01/2016 - 06/2012
2cholesteronitroneIBA
07/2022 - 03/2020
2Hydroxyl RadicalIBA
03/2022 - 01/2020
2purineIBA
03/2022 - 01/2015
2Peptides (Polypeptides)IBA
08/2021 - 07/2020
2phenyl-N-tert-butylnitroneIBA
02/2021 - 01/2020
2Dihydrotachysterol (AT 10)IBA
10/2020 - 03/2020
2Amyloid beta-PeptidesIBA
07/2020 - 08/2016
2Therapeutic UsesIBA
03/2020 - 01/2017
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2020 - 01/2017
2MetalsIBA
01/2020 - 06/2014
2quinolineIBA
08/2016 - 01/2012
2N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamineIBA
01/2016 - 07/2014
1BoratesIBA
07/2022
1pyrimidineIBA
03/2022
1Lipoxygenase (Lipoxygenase-1)IBA
03/2022
1InflammasomesIBA
01/2022
1calcipotriene (calcipotriol)FDA LinkGeneric
08/2021
1Glycogen Synthase KinasesIBA
01/2021
1tetramethylpyrazineIBA
11/2020
13-n-butylphthalide (butylphthalide)IBA
11/2020
1Choline O-Acetyltransferase (Choline Acetyltransferase)IBA
07/2020
1QuinolonesIBA
05/2020
1Free Radical ScavengersIBA
03/2020
1pyridineIBA
03/2020
1IronIBA
01/2020
1Mitochondrial Permeability Transition PoreIBA
01/2020
1Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020
1Protein Kinase CIBA
01/2020
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
12/2019
1LipopolysaccharidesIBA
12/2019
16- hydroxy- 2,5,7,8- tetramethylchroman- 2- carboxylic acid (Trolox)IBA
10/2019
1Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2019
1Type I Tumor Necrosis Factor ReceptorsIBA
12/2018
1Histamine (Histamine Dihydrochloride)FDA Link
10/2017
1CurcuminIBA
01/2017
1BerberineIBA
01/2017
1Serotonin ReceptorsIBA
01/2017
1TamoxifenFDA LinkGeneric
01/2017
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2017
1Formaldehyde (Formol)FDA Link
11/2016

Therapy/Procedure

37Therapeutics
08/2021 - 09/2011
1Intravenous Administration
06/2022